Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected Cases

N/AActive Not RecruitingNCT07048652

Superior University68 enrolled

Overview

This will be a cross-sectional descriptive study aimed at evaluating the role of high-resolution computed tomography (HRCT) in diagnosing Idiopathic Pulmonary Fibrosis (IPF).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

High-Resolution Computed TomographyDIAGNOSTIC_TEST

High-resolution computed tomography (HRCT) plays a crucial role in diagnosing and managing Idiopathic Pulmonary Fibrosis (IPF). It helps identify the characteristic pattern of IPF, known as Usual Interstitial Pneumonia (UIP), and can sometimes obviate the need for lung biopsy.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 18 years and above. * Patients clinically suspected of having IPF. * Patients referred for HRCT examination. * Patients who provide informed consent to participate in the study. Exclusion Criteria: * Patients with a known diagnosis of other interstitial lung diseases. * Patients with comorbid conditions that could mimic IPF. * Patients who are pregnant. * Patients with incomplete medical records or imaging studies

Locations (1)

AYK Hospital

Lahore, Pakistan

Outcomes

Primary Outcomes

high-resolution computed tomography (HRCT)

Idiopathic Pulmonary Fibrosis (IPF) high-resolution computed tomography (HRCT) scans are crucial for diagnosis and assessment of disease severity. HRCT findings typically show a reticular pattern with traction bronchiectasis and honeycombing, predominantly in the subpleural and basal regions of the lungs

Time frame: 12 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.